British Journal of Haematology

THE ROLE OF GRANULOCYTE- AND GRANULOCYTE-MACROPHAGE-COLONY-STIMULATING FACTORS IN THE TREATMENT OF ACUTE MYELOID LEUKAEMIA
pp. 1-8(8)
Authors: Johnson, Peter R. E.; Liu Yin, John A.

Cytokine and chemokine production by CD34⁺ haemopoietic progenitor cells: detection in single cells
pp. 9-14(6)
Authors: Behringer, Dirk; Kresin, Vera; Henschler, Reinhardt; Mertelsmann, Roland; Lindemann, Albrecht

The role of CS1 moiety of fibronectin in VLA4-mediated haemopoietic progenitor trafficking
pp. 15-21(7)
Authors: Craddock, C. F.; Nakamoto, B.; Elices, M.; Papayannopoulou, Th

Diverse effects of anti-CD44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vitro
pp. 22-28(7)
Authors: Ghaffari, Saghi; Dougherty, GraemeJ.; Eaves, AllenC.; Eaves, ConnieJ.

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma
pp. 29-37(9)
Authors: WislØff, Finn; Hjorth, Martin

Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma
pp. 38-45(8)
Authors: Joshua, DouglasE.; Penny, Ron; Matthews, JaneP.; Laidlaw, ChristineR.; Gibson, John; Bradstock, Ken; Wolf, Max; Goldstein, David

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage
pp. 46-55(10)
Authors: Rawstron, AndrewC.; Owen, RogerG.; Davies, FaithE.; Johnson, RoderickJ.; Jones, RichardA.; Richards, StephenJ.; Evans, PaulA.; Child, J. Anthony; Smith, GraemeM.; Jack, AndrewS.; Morgan, GarethJ.

Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen
pp. 56-64(9)
Authors: Schneider, Ulrike; Lessen, Antje van; Huhn, Dieter; Serke, Stefan

Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells
pp. 65-75(11)
Authors: Wyler, Beat; Shao, Ying; Schneider, Erasmus; Cianfriglia, Maurizio; Scheper, RikJ.; Frey, BeatM.; Gieseler, Frank; Schmid, Luzius; Twentyman, PeterR.; Lehnert, Manfred

Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score
pp. 76-85(10)
Authors: Hehlmann, R.; Ansari, H.; Hasford, J.; Heimpel, H.; Hossfeld, D. K.; Kolb, H. J.; Löffler, H.; Pralle, H.; Queisser, W.; Reiter, A.; Hochhaus, A.

Molecular response of CML patients treated with interferon-α monitored by quantitative Southern blot analysis
pp. 86-93(8)
Authors: Reiter, Andreas; Skladny, Heyko; Hochhaus, Andreas; Seifarth, Wolfgang; Heimpel, Hermann; Bartram, ClausR.; Cross, NicholasC. P.; Hehlmann, Rüdiger

Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease
pp. 94-98(5)
Authors: Podestà, Marina; Piaggio, Giovanna; Sessarego, Mario; Pitto, Anna; Benvenuto, Federica; Vassallo, Franca; Fugazza, Giuseppina; Carella, AngeloM.; Frassoni, Francesco

Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques
pp. 99-106(8)
Authors: Haferlach, Torsten; Winkemann, Martin; Nickenig, Christina; Meeder, Marlies; Ramm-Petersen, Lotte; Schoch, Robert; Nickelsen, Maike; Weber-Matthiesen, Klaus; Schlegelberger, Brigitte; Schoch, Claudia; Gassmann, Winfried; Löffler, Helmut

Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia
pp. 107-112(6)
Authors: Demeter, Judith; Porzsolt, Franz; Rämisch, Stephanie; Schmidt, Dorothee; Schmid, Mathias; Messer, Gerald

Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level
pp. 113-118(6)
Authors: Brugiatelli, M.; Claisse, J. F.; Lenormand, B.; Morabito, F.; Callea, V.; Malloum, K.; Chevret, S.; Binet, J. L.; Dighiero, G.; Travade, P.

Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas
pp. 119-122(4)
Authors: AVET-LOISEAU, Hervé; VIGIER, Magda; MOREAU, Anne; MELLERIN, Marie-Paule; GAILLARD, Fanny; HAROUSSEAU, Jean-Luc; Bataille, Régis; MILPIED, Noël

Constitutive expression of Fas ligand in large granular lymphocyte leukaemia
pp. 123-126(4)
Authors: Perzova, Raisa; Loughran, ThomasP.

Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia
pp. 127-131(5)
Authors: Hasle, Henrik; Olsen, JØrgenH.

Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in hairy cell leukaemia
pp. 132-134(3)
Authors: Demeter, Judith; Porzsolt, Franz; RÄmisch, Stephanie; Schmid, Mathias; Messer, Gerald

Trisomy 8 in a patient who responded to therapy with all-trans-retinoic acid and developed paroxysmal nocturnal haemoglobinuria
pp. 135-136(2)
Authors: Viniou, N.; Michali, E.; Meletis, J.; Andreopoulos, A.; Vaiopoulos, G.; Stavroyianni, N.; Loukopoulos, D.; Yataganas, X.

Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acid
pp. 137-140(4)
Authors: Takeuchi, Makoto; Yano, Tomofumi; Omoto, Eijiro; Takahashi, Kiyoshi; Kibata, Masayoshi; Shudo, Koichi; Ueda, Ryuzo; Ohno, Ryuzo; Harada, Mine

Flow cytometric method for the routine follow-up of red cell populations after bone marrow transplantation
pp. 141-145(5)
Authors: Hendriks, E. C. M.; deMan, A. J. M.; vanBerkel, Y. C. M.; Stienstra, S.; deWitte, T.

G-CSF-mobilized CD34⁺ peripheral blood stem cells are significantly less apoptotic than unstimulated peripheral blood CD34⁺ cells: role of G-CSF as survival factor
pp. 146-152(7)
Authors: Philpott, N. J.; Prue, R. L.; Marsh, J. C. W.; Gordon-Smith, E. C.; Gibson, F. M.

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma
pp. 153-160(8)
Authors: RAJE, NOOPUR; POWLES, RAY; KULKARNI, SAMAR; MILAN, SARAH; MIDDLETON, GARY; SINGHAL, SEEMA; MEHTA, JAYESH; MILLAR, BARBARA; VINER, CHRISTINE; RAYMOND, JULIAN; TRELEAVEN, JENNIFER; CUNNINGHAM, DAVID; GORE, MARTIN

Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes
pp. 161-164(4)
Authors: Keil, Felix; Kalhs, Peter; Haas, OskarA.; Fritsch, Gerhard; Reiter, Elisabeth; Mannhalter, Christine; Lechner, Klaus; Leitner, Gerda; Greinix, HildegardT.

Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation
pp. 165-168(4)
Authors: ATRA, A.; MILLAR, B.; SHEPHERD, V.; SHANKAR, A.; WILSON, K.; TRELEAVEN, J.; PRITCHARD-JONES, K.; MELLER, S. T.; PINKERTON, C. R.

Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria
pp. 169-174(6)
Authors: Kurtzhals, J. A. L.; Rodrigues, O.; Addae, M.; Commey, J. O. O.; Nkrumah, F. K.; Hviid, L.

Successful treatment of chronic severe neutropenia with weekly recombinant granulcyte-colony stimulating factor
pp. 175-178(4)
Authors: Fine, KennethD.; Byrd, TomD.; Stone, MarvinJ.

Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin
pp. 179-184(6)
Authors: vanGenderen, PerryJ. J.; Mulder, PaulG. H.; Waleboer, Marco; van deMoesdijk, Desiree; Michiels, JanJ.

Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets
pp. 185-191(7)
Authors: SAVI, P.; ARTÇANUTHURRY, V.; BORNIA, J.; GRELAC, F.; MACLOUF, J.; LEVY-TOLEDANO, S.; HERBERT, J. M.

Immunolocalization of the multi-sarco/endoplasmic reticulum Ca²⁺ATPase system in human platelets
pp. 192-203(12)
Authors: Kovàcs, Tündé; Berger, Gaetan; Corvazier, Elisabeth; Pàszty, Katalin; Brown, Angie; Bobe, Régis; Papp, Béla; Wuytack, Frank; Cramer, ElisabethM.; Enouf, Jocelyne

Interlaboratory variation in the detection of clinically significant alloantibodies against human platelet alloantigens
pp. 204-207(4)
Authors: Metcalfe, P.; Allen, D.; Chapman, J.; Ouwehand, W. H.

THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS
pp. 208-213(6)
Authors: Simpson, A. J.; Gray, R. S.; Moore, N. R.; Booth, N. A.

Protection by α2-macroglobulin of tissue plasminogen activator against inhibition by plasminogen activator inhibitor-1
pp. 214-218(5)
Authors: IEKO, M.; SAWADA, K.; YASUKOUCHI, T.; SAKURAMA, S.; TOHMA, Y.; SHIROSHITA, K.; KUROSAWA, S.; OHMOTO, A.; KOHNO, M.; SATOH, M.; KOIKE, T.

Identification of a Monoclonal Thrombin Inhibitor Associated with Multiple Myeloma and a Severe Bleeding Disorder
pp. 219-226(8)
Authors: Colwell, NiallS.; Tollefsen, DouglasM.; Blinder, MoreyA.

Anti-endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies
pp. 227-232(6)
Authors: Matsuda, Juzo; Gotoh, Moritaka; Gohchi, Kengo; Kawasugi, Kazuo; Tsukamoto, Miyo; Saitoh, Noriko

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives
pp. 233-238(6)
Authors: Rosing, J.; Tans, G.; Nicolaes, G. A. F.; Thomassen, M. C. L. G. D.; vanOerle, R.; van der Ploeg, P. M. E. N.; Heijnen, P.; Hamulyak, K.; Hemker, H. C.